肿瘤的分子靶向治疗
Molecular targeted therapy for cancer
出处
《河南医学研究》
CAS
2008年第2期189-192,共4页
Henan Medical Research
参考文献19
-
1汤军桥,葛海良.卵巢癌基因治疗的研究现状及进展[J].国外医学（妇产科学分册）,2006,33(4):259-263. 被引量：2
-
2Krohn TU, Shankara S, Gelssler M, et al. Mechanisms of cell death induced by suicide encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocllular carcinoma cell in vitro. [ J ]. H epatology, 2001,34 ( 3 ) : 511-518. 被引量：1
-
3Wu H,Hait WN ,Yang JM. Small interfering RNA - induced suppression of MDR1 (P-glycoprotein) restores sensitivity to muhiclrug-resistant cancer cells. [ J ]. Cancer Res,2003,63 (7) : 1515-1519. 被引量：1
-
4徐伟,陈建利,张佳荣,杨懿霞,万小平.ATP7B基因反义寡核苷酸对卵巢癌SKOV3ipl细胞顺铂敏感性的影响[J].肿瘤,2006,26(1):28-31. 被引量：4
-
5Danny A, Paul FK, Pete H, et al. Towards Tissue Specific RNA interference-A Study of Novel RNAi Delivery Vectors Designed to Achieve Suppression Using a Polymerase II Transcribed Single Transcript. [J]. Ulster Med J,2007,76( 1 ) : 51-59 被引量：1
-
6Wang YH, Liu S, Zhang G, et al. Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. [ J ]. Breast Cancer Res ,2005,7 (2) :220-228. 被引量：1
-
7Yonesaka K, Tamura K, Kurata T, et al. Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adri-amycin. [ J ]. Int J Cancer,2006,118 ( 3 ) : 812-820. 被引量：1
-
8Hannon GJ. RNA interference. [ J]. Nature, 2002, 418 (6894) :244- 251. 被引量：1
-
9寇伯君,李玉林,张丽红,朱桂彬,王心蕊,李一雷,王悦增,石英爱.可溶性血管内皮生长因子受体2片段的克隆、表达及其在肿瘤血管形成中的作用[J].中华肿瘤杂志,2004,26(6):337-341. 被引量：9
-
10Forbes JF, Plenkowski T, Valero V, et al. BCIRG 007: Randomized phase Ⅲ trial of trastuzumab plus docetaxel with or without carboplatin first line in HER2 positive metastatic breast cancer (MBC). [J]. Clin Oncol, 2006, 24(18S) :LBAS16. 被引量：1
二级参考文献44
-
1唐云霞,陈瑜,顾锦法,齐荣,邹卫国,蒋琳兰,刘新垣.Ad.TERT-TRAIL对肿瘤细胞的杀伤作用及其机理[J].癌症,2005,24(5):536-542. 被引量：5
-
2Li G Sham J Yang J Su C Xue H Chua D Sun L Zhang Q Cui Z Wu M Qian Q.Potent antitumor efficacy of an E1B 55kDa-deficient adenovirus carrying murine endostatin in hepatocellular carcinoma[J].第二军医大学学报,2005,26(11):1330-1330. 被引量：9
-
3SUMMERTON J.Morpholino antisense oligomers:the case for an RNase H-independent structural type[J].Biochim Biophys Acta,1999,1489(1):141-158. 被引量：1
-
4SOLIOZ M,VULPE C.CPx-type ATPases:a class of P-type ATPases that pump heavy metals[J].Trends Biochem Sci,1996,21(7):237-241. 被引量：1
-
5RENSING C,MITRA B,ROSEN B P.The zntA gene of Escherichia coli encodes a Zn(Ⅱ)-translocating P type ATPase[J].Proc Natl Acad Sci USA,1997,94(26):14326-14331. 被引量：1
-
6GUPTA A,MATSUI K,LO J F,et al.Molecular basis for resis-tance to silver cations in Salmonella[J].Nat Med,1999,5(2):183-188. 被引量：1
-
7NAKAYAMA K,MIYAZAKI K,KANZAKI A,et al.Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines[J].Oncol Rep,2001,8(6):1285-1287. 被引量：1
-
8SAFAEI R,HOLZER A K,KATANO K,et al.The role of copper transporters in the development of resistance to Pt drugs[J].J Inorg Biochem,2004,98(10):1607-1613. 被引量：1
-
9韩复生 张霆钧.抗癌药物耐药性的检测[M].北京:北京出版社,1995.436-452. 被引量：1
-
10SEE H T,KAVANAGH J J.Novel agents in epithelial ovarian cancer[J].Cancer Invest,2004,22 (S2):29-44. 被引量：1
共引文献21
-
1刘军,吕建新,胡云良.血管内皮生长因子与小细胞肺癌[J].肿瘤研究与临床,2007,19(7).
-
2孙强,赵静,杜爱英,吴学君,金星,张尚立,苗俊英.血管瘤细胞培养及其生物学特性分析[J].中国现代普通外科进展,2005,8(5):307-308. 被引量：9
-
3陈公琰,洪璇.血管内皮生长因子与肺癌的关系[J].中华肿瘤杂志,2005,27(8):449-451. 被引量：27
-
4阚兵,姜愚,杨金亮,陈县城,胡敏,魏于全.小鼠sFlt重组腺病毒抑制小鼠Lewis肺癌的生长[J].中国肺癌杂志,2005,8(6):501-503.
-
5郑勇斌,赫杰,谭海燕,陈道达.转基因联合泰素帝治疗耐药结直肠癌[J].中华实验外科杂志,2006,23(7):798-799. 被引量：1
-
6Xin Yuan Liu~(1,2) ~1Institute of Biochemistry and Cell Biology,Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences,320 Yue Yang Road,Shanghai 200031,China,~2Xinyuan Institute of Medicine and Biotechnology,School of Life Science,Zhejiang Sci-Tech University,Hangzhou 310018,China.Targeting Gene-Virotherapy of Cancer and its prosperity[J].Cell Research,2006,16(11):879-886. 被引量：32
-
7于伟霞,何淑雅,袁皓瑜,廖端芳.腺病毒载体的改进策略[J].南华大学学报（医学版）,2007,35(3):449-451.
-
8黄明文,邵江华.人端粒酶逆转录酶基因启动子在肿瘤靶向性基因治疗中的作用[J].实用临床医学（江西）,2007,8(9):132-135. 被引量：1
-
9Qiu-wei PAN,Su-yang ZHONG,Bi-sheng LIU,Jin LIU,Rong CAI,Yi-gang WANG,Xin-yuan LIU,Cheng QIAN.Enhanced sensitivity of hepatocellular carcinoma cells to chemotherapy with a Smac-armed oncolytic adenovirus[J].Acta Pharmacologica Sinica,2007,28(12):1996-2004. 被引量：16
-
10董坚,陈明清,杨军,王熙才,伍治平,陈艳,王志强,李淼.重组减毒沙门氏菌疫苗SL3261-pcDNA3．1+/flk-1_(n1-4)抗小鼠大肠癌的生长[J].世界华人消化杂志,2008,16(2):163-170. 被引量：1
-
1陈开印.郑州大学揭示卵巢肿瘤癌癌变基因[J].首都医药,2002,9(5):42-42.
-
2TimCard,RichardLogan,王礼建,钱家鸣.结肠直肠癌：预防和早期诊断[J].国际内科双语杂志（中英文）,2004,4(3):37-39.
-
3贺大林,李磊.根治性放疗和根治性手术对于早期前列腺癌孰优孰劣[J].现代泌尿外科杂志,2013,18(4):394-394. 被引量：1
-
4韦静夫.自己救自己 康复最彻底[J].现代养生,2008(3):38-39.
-
5余天雾,陈新,余正,龚建平.胰腺癌基因治疗靶点研究现状[J].中国现代普通外科进展,2011,14(8):626-629. 被引量：2
-
6杨维良,张新晨.胃癌基因治疗的现状及展望[J].中华实验外科杂志,2004,21(5):639-640. 被引量：11
-
7肖光莉.手术与术后放疗之间的间隔时间对预后的影响[J].华夏医药,2005,9(3):217-220.
-
8于则利.胆囊癌早期诊断与治疗源头疾病的探讨[J].华夏医药,2007,2(4):262-264.
-
9魏亚珍.肝癌切除的护理[J].中外健康文摘,2009,6(04X):169-169.
-
10耿菁,代华平.抑癌基因PTEN在呼吸系统疾病中的研究进展[J].中华医学杂志,2013,93(30):2404-2406.
